30Jul
Increased regulatory scrutiny of foreign direct investments in the healthcare sector
Key Takeaways - - Foreign Direct Investment (FDI) controls are proliferating around the globe. Since the pandemic, “health” has become a particular focus. - Several countries have adapted their existing FDI rules, or introduced new ones, to address concerns about national autonomy and supply chain disruption. Some of these changes are general, but some are specific to healthcare. - Plans for cross-border M&A in the healthcare sector should take close account of potential FDI screening...
By:
Dechert LLP
Related
On October 15, 2020, the US Securities and Exchange Commission (SEC) issued a cease and desist order...
Read More >
NLRB Proposes Election Changes. On August 9, 2019, the National Labor Relations Board issued a notic...
Read More >
What’s the Deal? Special purpose acquisition companies (“SPACs”), commonly referred to as “blan...
Read More >
Effective January 1, 2020, the minimum wage in Ohio will be $8.70 per hour for non-tipped employees ...
Read More >
This alert sets out legislative, regulatory and “advisory” developments in respect of corporate go...
Read More >
Fiat Chrysler and rival Peugeot have agreed to binding merger terms that, if approved by US and Euro...
Read More >